Tag
This study investigates how semaglutide exposure before and during pregnancy affects gestational weight gain and key pregnancy outcomes in women with overweight or obesity, highlighting increased risks that may stem from treatment discontin
In a retrospective cohort of pregnancies complicated by type 2 diabetes, gestational weight gain under 5 kg was associated with lower odds of several adverse perinatal outcomes without a statistically significant rise in preterm birth or sm
This review synthesizes recent evidence suggesting that weight gain <5 kg in pregnant individuals with type 2 diabetes significantly reduces risks of LGA, hypertensive disorders, and NICU admissions without increasing SGA rates.
In a large retrospective cohort, women who discontinued GLP‑1 receptor agonists shortly before or during early pregnancy had greater gestational weight gain and higher risks of preterm birth, gestational diabetes, and hypertensive disorders
This analysis reveals that metabolic health phenotypes, rather than gestational weight gain alone, significantly influence maternal and infant outcomes in prenatal behavioral interventions among obese pregnant women.
A 17-year cohort study links excessive gestational weight gain to long-term postpartum obesity and weight retention, especially in Black and Dominican women, highlighting the need for targeted interventions during pregnancy.
